Literature DB >> 21633953

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.

Regalla Kumarswamy1, Giridhar Mudduluru, Paolo Ceppi, Santoshi Muppala, Miroslaw Kozlowski, Jacek Niklinski, Mauro Papotti, Heike Allgayer.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs which regulate gene expression by base-pairing to the 3'-UTR of the target mRNA. Recently, miRNAs have been shown to regulate cancer metastasis, however, central molecular mechanisms of this ability still need to be investigated. Epithelial to mesenchymal transition (EMT), which is characterized especially by repression of E-cadherin expression and increased cell motility, is an essential component of cancer metastasis and progression. In the present study, we found that Snai1, a known transcriptional repressor of E-cadherin and modulator of EMT, is post-transcriptionally targeted by miRNA-30a in non-small cell lung cancer (NSCLC). Consistent with this, microRNA-30a expression was found inversely proportional to the invasive potential of various NSCLC cell lines, correlating positively with E-cadherin (epithelial marker) and negatively with N-cadherin (mesenchymal marker) expression. Forced re-introduction of miR-30a significantly altered cell morphology, in vitro invasion and migration of invasive cell lines, this being paralleled by a downregulation of Snai1 and upregulation of E-cadherin expression. Using a chicken embryonic metastasis assay, we found that miR-30a suppresses in vivo distant metastasis to the lungs and liver. Finally, we screened the expression of miR-30a in 64 consecutively resected NSCLC patients and found that, in 81% of the patients, expression of miR-30a was downregulated significantly (p < 0.0001) in tumors compared to corresponding normal tissues. These results suggest that miR-30a targets Snai1, inhibits invasion and metastasis, and is downregulated in NSCLC.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633953     DOI: 10.1002/ijc.26218

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  128 in total

1.  Mechanical loading and TGF-β change the expression of multiple miRNAs in tendon fibroblasts.

Authors:  Christopher L Mendias; Jonathan P Gumucio; Evan B Lynch
Journal:  J Appl Physiol (1985)       Date:  2012-04-26

2.  Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis.

Authors:  Vahab D Soleimani; Hang Yin; Arezu Jahani-Asl; Hong Ming; Christel E M Kockx; Wilfred F J van Ijcken; Frank Grosveld; Michael A Rudnicki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

3.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Authors:  Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

Review 4.  Microenvironmental regulation of cancer metastasis by miRNAs.

Authors:  Yun Zhang; Pengyuan Yang; Xiao-Fan Wang
Journal:  Trends Cell Biol       Date:  2013-10-11       Impact factor: 20.808

5.  MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1.

Authors:  Jenean H O'Brien; Laura Hernandez-Lagunas; Kristin Bruk Artinger; Heide L Ford
Journal:  J Cell Sci       Date:  2014-03-14       Impact factor: 5.285

Review 6.  The role of EMT and MET in cancer dissemination.

Authors:  Jacqueline Banyard; Diane R Bielenberg
Journal:  Connect Tissue Res       Date:  2015-08-20       Impact factor: 3.417

Review 7.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

8.  Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy.

Authors:  Peng Wang; Jia Liang; Yun Li; Jiefei Li; Xuan Yang; Xinxin Zhang; Song Han; Shujuan Li; Junfa Li
Journal:  Neurochem Res       Date:  2014-04-26       Impact factor: 3.996

9.  Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs.

Authors:  Giovanni Nassa; Roberta Tarallo; Giorgio Giurato; Maria Rosaria De Filippo; Maria Ravo; Francesca Rizzo; Claudia Stellato; Concetta Ambrosino; Marc Baumann; Niina Lietzèn; Tuula A Nyman; Alessandro Weisz
Journal:  Mol Cell Proteomics       Date:  2014-02-13       Impact factor: 5.911

10.  miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

Authors:  Myriem Boufraqech; Naris Nilubol; Lisa Zhang; Sudheer Kumar Gara; Samira M Sadowski; Amit Mehta; Mei He; Sean Davis; Jennifer Dreiling; John A Copland; Robert C Smallridge; Martha M Quezado; Electron Kebebew
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.